Peritoneal Dialysis Tidal-Dwell Sequencing for Toxin Clearance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing peritoneal dialysis methods may not adequately address the removal of toxins and ultrafiltration needs for patients with varying peritoneal membrane transport characteristics, leading to inefficiencies and discomfort.

Innovation Solution

A method involving alternating tidal therapy and dwell phases with hypertonic solutions, combined with dialysis sorbents and calcium/magnesium ions, to enhance toxin clearance and ultrafiltration without increasing sorbent use.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If tidal peritoneal dialysis is used to remove toxins, then toxin clearance is improved, but ultrafiltration efficiency deteriorates

Engineering Contradiction:
Improvetoxin clearanceVSAvoidultrafiltration efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent implements periodic action by alternating between tidal therapy phases (for toxin removal) and dwell phases (for ultrafiltration). The cycler automatically performs multiple cycles of filling, draining, and dwelling with hypertonic solutions, creating periodic oscillations that separately optimize toxin clearance and ultrafiltration without requiring simultaneous execution of both functions

Inventive Principle:
Principle #19Periodic action

2Reliability

If additional dwell time is added to achieve required tonicity, then dialysis efficacy is improved, but treatment time increases

Engineering Contradiction:
Improvedialysis efficacyVSAvoidtreatment time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies parameter changes by using hypertonic solutions (higher than normal tonicity) during dwell phases. This parameter modification allows the peritoneal membrane to achieve required tonicity more rapidly, improving dialysis efficacy while reducing the time needed for each dwell phase compared to using isotonic or hypotonic solutions

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If small tidal volume is moved frequently, then patient comfort is improved, but toxin removal efficiency deteriorates

Engineering Contradiction:
Improvepatient comfortVSAvoidtoxin removal efficiency
Core Design Contradiction:
Ease of operationVSQuantity of substance

Solution Approach 1:

The patent applies local quality by creating different functional zones within the peritoneal dialysis system: small tidal volumes are used during active exchange phases to maintain patient comfort, while hypertonic dwell phases create localized high-concentration regions that enhance toxin removal. The automated cycler manages these different local conditions sequentially without requiring the entire system to operate at maximum intensity simultaneously

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach achieves enhanced toxin clearance and ultrafiltration, meeting or exceeding the KDIGO guidelines for dialysis efficacy without requiring additional fluid or sorbents, thus improving patient comfort and treatment efficiency.

Implementation Method 1

allowing water and/or a toxin from the subject to pass into the peritoneal cavity by osmosis, thereby forming an Nth hypertonic solution within the peritoneal cavity

Methodology Applied
Scientific EffectOsmosis: Osmosis

Data Source

PatentUS20250269100A1Peritoneal dialysis methods
Publication Date: 2025.08.28 AWAK TECH PTE LTD
  • US20250269100A1 patent drawing
  • US20250269100A1 patent drawing
  • US20250269100A1 patent drawing

AI summary

Disclosed herein is a method of peritoneal dialysis, the method comprising the steps of: (i) administering to a subject a first hypertonic solution comprising a sugar to a peritoneal cavity in the subject, followed by; (ii) a tidal therapy phase and then a dwell phase; or a dwell phase and then a tidal therapy phase.